| For: | Pasari AS, Malde S, Tolani P, Ramteke V, Gupta S, Pawar T, Jeyachandran V, Sejpal K, Kurundwadkar M, Gurjar P, Kashiv P, Dubey S, Bawankule C, Kute VB, Deshpande N, Balwani MR. Impact of cytochrome P450 3A5 expression on clinical outcomes in renal transplant recipients receiving tacrolimus-based immunosuppression. World J Transplant 2025; 15(4): 107636 [PMID: 41357367 DOI: 10.5500/wjt.v15.i4.107636] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v15/i4/107636.htm |
| Number | Citing Articles |
| 1 |
Jia You, Hongxia Liu, Yunyun Yang, JiaZhao Fu, Mingxing Sui, Wenyu Zhao, Zhilong Yuan, Tao Ma, Zhuo Wang, Xuebin Wang. ABCC2 rs2273697 is an independent determinant of tacrolimus intra-patient variability during the first year after kidney transplantation. International Journal of Clinical Pharmacy 2026; doi: 10.1007/s11096-026-02117-z
|
